Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 14, 2017	UPLOAD	UPLOAD	0000000000-17-005267.pdf View HTML
February 13, 2017	8-K	Report of unscheduled material events or corporate event	0001193125-17-039296.pdf 0001193125-17-039296.rtf 0001193125-17-039296.xls View HTML
February 13, 2017	SC 13G/A	An amendment to the SC 13G filing	0001193125-17-039994.pdf 0001193125-17-039994.rtf 0001193125-17-039994.xls View HTML
February 10, 2017	5	Annual filing director officer or owner of more than ten percent.	0001562180-17-000613.pdf 0001562180-17-000613.rtf 0001562180-17-000613.xls View HTML
January 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000318.pdf 0001562180-17-000318.rtf 0001562180-17-000318.xls View HTML
January 20, 2017	CORRESP	CORRESP	0001193125-17-014153.pdf 0001193125-17-014153.rtf 0001193125-17-014153.xls View HTML
January 19, 2017	SC 13G/A	An amendment to the SC 13G filing	0000215457-17-001222.pdf 0000215457-17-001222.rtf View HTML
January 6, 2017	CORRESP	CORRESP	0001193125-17-004707.pdf 0001193125-17-004707.rtf View HTML
January 3, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000082.pdf 0001562180-17-000082.rtf 0001562180-17-000082.xls View HTML
January 3, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000081.pdf 0001562180-17-000081.rtf 0001562180-17-000081.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax